{
    "code": 0,
    "data": [
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Quarter Ended December 31 2025.",
            "news_body": "Unaudited Financial Results of the Company for the quarter ended December 31 2025.",
            "news_id": "cbcee84f-adaf-432f-b69b-dbad5ddded9d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=580fb90c-b714-4e84-8cd6-d07dcd6ddcf6.pdf",
            "news_date": "2026-02-12 13:33:16",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended September 30 2025.",
            "news_body": "Unaudited financial results for the quarter ended September 30 2025.",
            "news_id": "5a1d6cdd-30e7-4c68-b205-3b4ca1efb2f0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54186b0c-acef-45e7-8ca4-7bbd1ecae0ae.pdf",
            "news_date": "2025-11-06 13:33:15",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30 2025.",
            "news_body": "Unaudited Financial Results for the quarter ended June 30 2025.",
            "news_id": "e762842b-ed87-48bf-bf82-4cd03cd89f04",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2697b15-bbc8-45e5-beac-f470b7dc0a66.pdf",
            "news_date": "2025-08-12 13:16:02",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting.",
            "news_id": "1d35456b-e5fd-4a86-9c90-a0631d7afcd6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=169a7fa4-35a3-4031-8c5c-8c9496db16e8.pdf",
            "news_date": "2025-08-12 13:07:48",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Financial Year Ended March 31 2025",
            "news_body": "Results for the financial year ended March 31 2025",
            "news_id": "7274479f-f26a-4987-a632-1f0744b2b15f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d242426-6c1f-4aff-a096-6e083c6c3f4f.pdf",
            "news_date": "2025-05-15 19:03:51",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "Unaudited Financial Results for the quarter and nine months ended December 31 2024",
            "news_id": "819391ef-71c2-41a7-8bba-ffc0810bc4d8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae901a61-4364-4b2e-9fc4-0b119dbc61a3.pdf",
            "news_date": "2025-02-05 13:25:23",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024",
            "news_body": "Unaudited Financial Results for the quarter and half year ended September 30, 2024",
            "news_id": "ef91f671-897a-4825-9e8e-37f0d6c07b74",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e78f1fc-f839-4656-b53a-15e7e5e2e021.pdf",
            "news_date": "2024-11-07 13:29:19",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The First Quarter Ended On June 30, 2024",
            "news_body": "Unaudited Financial Results of the Company for the first quarter ended on June 30, 2024",
            "news_id": "aef52493-d3c4-4c96-abb9-eb550e657c6f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0b208f2-8f32-452d-a55f-dc2db8f13136.pdf",
            "news_date": "2024-08-07 17:53:05",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Financial Year Ended March 31, 2024",
            "news_body": "Financial Results for the quarter and financial year ended March 31, 2024.",
            "news_id": "ddf9855c-24b8-4a97-b9a0-afda6fd29f5a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5864d65e-94e8-4ce5-986f-22aa3250a98a.pdf",
            "news_date": "2024-05-09 18:36:35",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Third Quarter And Nine Months Ended On December 31, 2023",
            "news_body": "Unaudited Financial Results of the Company for the third quarter and nine months ended on December 31, 2023",
            "news_id": "58ef720e-987b-42da-aaf1-829428d4b6f4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6b55f4b-9cf3-4c36-9198-0e50c6b0dcf6.pdf",
            "news_date": "2024-02-01 17:46:12",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended On September 30, 2023",
            "news_body": "Unaudited Financial Results of the Company for the second quarter and half year ended on September 30, 2023",
            "news_id": "64cfcff5-ccdf-44c5-a861-59a660c5273d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=00dbfba8-ce70-402a-a775-1a18fa6b540f.pdf",
            "news_date": "2023-11-09 13:39:00",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The First Quarter Ended On June 30, 2023",
            "news_body": "Unaudited Financial Results of the Company for the first quarter ended June 30, 2023.",
            "news_id": "6c34c50c-7c28-4a50-ba67-7834318f46f5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48c3057f-800d-4af5-9616-e5be79145eed.pdf",
            "news_date": "2023-08-09 18:53:42",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a text of Unaudited Financial Results of the Company for the first quarter ended on June 30, 2023, approved by the Board of Directors at its Meeting held on today i.e., Wednesday, August 9, 2023 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company.<BR> <BR> The Meeting of the Board of Directors of the Company commenced at 3.30 pm and concluded at 6.45 pm.<BR> <BR>",
            "news_id": "006b0176-f305-4dc0-b323-0c240d1e2f42",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca8cba65-654c-41b8-8c27-e721b15786be.pdf",
            "news_date": "2023-08-09 18:49:55",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results Of The Company For The Quarter And Year Ended On March 31, 2023",
            "news_body": "Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose a copy of the Audited Financial Results of the Company for the quarter and year ended on  March 31, 2023 along with Statement of Assets and Liabilities as on that date and Statement of Cash Flow, as approved by the Board of Directors at its Meeting held today i.e. May 19, 2023, along with the Auditor's Report issued by S R B C & CO LLP, Statutory Auditors of the Company. <BR> <BR> Further, pursuant to Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we confirm that S R B C & CO LLP, Statutory Auditors have issued the Audit Report with unmodified opinion for the year ended March 31, 2023.   A declaration to that effect from the Company is enclosed.<BR> <BR> The Meeting of the Board of Directors of the Company commenced at 11.30 am and concluded at 3.50 pm.<BR>",
            "news_id": "de9f34b7-3976-47f1-bb56-8e3f30ff2f8f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4af65fde-2a0d-4c22-a2a3-9a6c10803034.pdf",
            "news_date": "2023-05-19 16:03:44",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results Of The Company For The Third Quarter Ended On December 31, 2022",
            "news_body": "Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose a text of Unaudited Financial Results of the Company for the third quarter ended on December 31, 2022, approved by the Board of Directors at its Meeting held today i.e., Friday, February 10, 2023 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company.    <BR> <BR> The Meeting of the Board of Directors of the Company commenced at 12.00 Noon and concluded at 1:50 pm.<BR> <BR> Kindly acknowledge the receipt of the same.<BR>",
            "news_id": "f97260d0-c5a7-4c9e-bbcc-e3d652081a65",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fac9259-ff0d-468c-a2f8-86ea87f54d87.pdf",
            "news_date": "2023-02-10 14:01:20",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions For The Half Year Ended September 30, 2022.",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose disclosure of Related Party Transactions for the half year ended September 30, 2022.The above disclosure is also available on the website of the Company at www.abbott.co.in.",
            "news_id": "901222cd-d3c2-4236-8d79-b5ebe8549049",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3a258b0-1d75-4f51-aa44-0216b525eaaa.pdf",
            "news_date": "2022-11-25 15:19:49",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended On September 30, 2022",
            "news_body": "Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose a text of Unaudited Financial Results of the Company for the second quarter and half year ended on September 30, 2022, approved by the Board of Directors at its Meeting held today i.e., Monday, November 14, 2022 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company.    <BR> <BR> The Meeting of the Board of Directors of the Company commenced at 11.30 am and concluded at 1.00 pm.<BR> <BR>",
            "news_id": "aeb31f0e-a67b-4525-a7f5-d7d0f68955b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a9c31af-716d-4507-8f5f-d4ccd34f80c8.pdf",
            "news_date": "2022-11-14 13:17:40",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results Of The Company For The First Quarter Ended On June 30, 2022",
            "news_body": "Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a text of Unaudited Financial Results of the Company for the first quarter ended on June 30, 2022, approved by the Board of Directors at its Meeting held on Wednesday, August 10, 2022 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company. <BR> <BR> The Meeting of the Board of Directors of the Company commenced at 4.00 pm and concluded at 5.30 pm.<BR> <BR> Kindly acknowledge the receipt of the same.<BR>",
            "news_id": "eb7f0d1c-fc8d-49ad-82d7-417a56158158",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57c9bf05-7d18-4a17-92b3-88ae1c93b80b.pdf",
            "news_date": "2022-08-10 17:39:04",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Disclosure On Related Party Transactions",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose disclosure of Related Party Transactions in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, for the half year ended March 31, 2022.The above disclosure is also available on the website of the Company at www.abbott.co.in. This is for your information and records.",
            "news_id": "d3a81230-127d-46c0-95db-2168c9a48c15",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5058e2e1-b34e-4582-8730-e2995ad6605f.pdf",
            "news_date": "2022-05-31 18:42:14",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results Of The Company For The Quarter And Year Ended On March 31, 2022",
            "news_body": "Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose a copy of the Audited Financial Results of the Company for the quarter and year ended on March 31, 2022 along with Statement of Assets and Liabilities as on that date and Statement of Cash Flow, as approved by the Board of Directors at its Meeting held today i.e. May 17, 2022, along with the Auditor's Report issued by S R B C & CO LLP, Statutory Auditors of the Company. <BR> <BR> Further, pursuant to Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby declare that, S R B C & CO LLP, Statutory Auditors have issued the Audit Report with unmodified opinion for the year ended  March 31, 2022.<BR> <BR> The Meeting of the Board of Directors of the Company commenced at 11.30 am and concluded at 2.20 p.m.<BR> <BR>",
            "news_id": "39640171-1bae-4da4-9538-a4e230326c2b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c564aa5-40a4-45d0-ab29-853f435add0b.pdf",
            "news_date": "2022-05-17 14:32:48",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended On December 31, 2021",
            "news_body": "Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a text of Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2021, approved by the Board of Directors at its Meeting held today i.e., Wednesday, February 9, 2022 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company.   <BR> <BR> The Meeting of the Board of Directors of the Company commenced at 11.30 am and concluded at 1.50 pm.<BR> <BR> Kindly acknowledge the receipt of the same.<BR>",
            "news_id": "4971ed10-bd32-43c0-a18c-c24e868fe71e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42e7a77c-682b-4320-b7ff-964be0900a3d.pdf",
            "news_date": "2022-02-09 14:11:27",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended On September 30, 2021",
            "news_body": "Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a text of Unaudited Financial Results of the Company for the second quarter and half year ended on September 30, 2021, approved by the Board of Directors at its Meeting held today i.e., Friday, November 12, 2021 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company.    <BR> <BR> The Meeting of the Board of Directors of the Company commenced at 10.00 am and concluded at 12.10 pm.<BR>",
            "news_id": "2057bf0d-9bc6-4088-a1e5-7356661b7cf5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=96052820-b472-4505-97c9-bcb208c6fea9.pdf",
            "news_date": "2021-11-12 12:37:56",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results Of The Company For The First Quarter Ended On June 30, 2021",
            "news_body": "Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a text of Unaudited Financial Results of the Company for the first quarter ended on June 30, 2021, approved by the Board of Directors at its Meeting held on Friday, August 6, 2021 along with the Limited Review Report issued by S R B C & CO. LLP, Statutory Auditors of the Company.<BR> <BR> The Meeting of the Board of Directors of the Company commenced at 10.45 am and concluded at 11.45 am.<BR> <BR> Kindly acknowledge the receipt of the same.<BR>",
            "news_id": "5ae66253-3a40-44f6-ac90-22c6d16146fd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b088f0c-dfca-41c3-8925-8f31cf0e2bcd.pdf",
            "news_date": "2021-08-06 12:05:34",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Under Regulation 23(9) Of The SEBI (LODR) Regulations, 2015 - Disclosure Of Related Party Transactions",
            "news_body": "Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed, disclosure of related party transactions on a consolidated basis, in the format specified in the Accounting Standards for the year ended March 31, 2021.<BR> <BR> The above disclosure is also available on the website of the Company i.e. www.abbott.co.in <BR> <BR> This is for your information and record.<BR>",
            "news_id": "05685629-5421-48b3-9e2f-9eb33372d902",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc943d34-efc0-4f24-8282-69a964aea786.pdf",
            "news_date": "2021-06-14 15:08:48",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ABBOTINDIA",
            "disp": "Abbott",
            "bse_code": 500488,
            "isin": "INE358A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2021",
            "news_body": "Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose a copy of the Audited Financial Results of the Company for the quarter and year ended on March 31, 2021 along with Statement of Assets and Liabilities as on that date and Statement of Cash Flow, as approved by the Board of Directors at its Meeting held today i.e. May 18, 2021, along with the Auditor's Report issued by S R B C & CO LLP, Statutory Auditors of the Company.  <BR> <BR> Further, pursuant to Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby declare that, S R B C & CO LLP, Statutory Auditors have issued the Audit Report with unmodified opinion for the year ended March 31, 2021.<BR> <BR> The Meeting of the Board of Directors of the Company commenced at 12.00 Noon and concluded at 2.30 p.m.<BR> <BR> This is for your information and records. <BR>",
            "news_id": "ef8e5839-3e68-425a-a7a1-712eefc66470",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea8389ea-bd82-4f94-a6c9-2866e13ba71a.pdf",
            "news_date": "2021-05-18 14:39:39",
            "seo": "abbott-india-ltd",
            "ltp": 26915,
            "ch": -380,
            "pch": -1.392196372962081,
            "inst": "EQUITY",
            "ts": 5,
            "ls": 1,
            "mtp": 1,
            "sid": 17903,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}